Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Brazil Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology ... Read More
-
Global Red Biotechnology Market - 2022-2029
... 5.2% during the forecast period (2022-2029). Red biotechnology indicates biopharmaceuticals. It involves the use of biotechnology in the medical field. It covers applications of biotechnology relating to clinical trials, vaccine development, disease research, antibiotic production, ... Read More
-
Lab Automation Software Market Forecasts to 2028 – Global Analysis By Software (Chromatography, Data System (CDS), Laboratory Information Management System (LIMS), Laboratory Information System (LIS), Scientific Data Management System (SDMS), Electronic Lab Notebook (ELN), Other Softwares), Application (Proteomics, Drug Discovery and Development, Clinical Diagnostics, Genomics, Other Applications), and Geography
... Softwares), Application (Proteomics, Drug Discovery and Development, Clinical Diagnostics, Genomics, Other Applications), and Geography According to Stratistics MRC, the Global Feeding Systems Market is accounted for $2.96 billion in 2022 and is expected to reach ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
... Component [Datasets (Clinical, Claims, Pharmacy), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029 The U.S. RWE solutions market is expected to grow at a CAGR of ... Read More
-
Global Nootropics Market 2022-2026
... the nootropics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global ... Read More
-
UV/Visible Spectroscopy
... year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 4.3% over the analysis period 2020-2027. Dual-Beam, one of the segments analyzed in the report, is ... Read More
-
COVID-19- Competitive Landscape, 2022
... and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage COVID-19: Understanding COVID-19: Overview Coronaviruses are a group of related viruses that cause diseases in mammals and ... Read More
-
TIGIT Inhibitors - Competitive Landscape, 2022
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage TIGIT inhibitors: Understanding TIGIT inhibitors: Overview T-cell immunoreceptor with Ig and ITIM domains ... Read More
-
TIGIT Inhibitors - Competitive Landscape, 2022
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage TIGIT inhibitors: Understanding TIGIT inhibitors: Overview T-cell immunoreceptor with Ig and ITIM ... Read More
-
Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030
... global pancreatic cancer market size is expected to reach USD 7.04 million by 2030, according to a new study by Polaris Market Research. The report “Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
RNA- Competitive Landscape, 2022
... and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage RNA: Understanding RNA: Overview RNA interference (RNAi) is one of the pathways, collectively named RNA silencing pathways ... Read More
-
Janus kinase (JAK) Inhibitors- Competitive Landscape, 2022
... therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Janus kinase (JAK) inhibitors: Understanding Janus kinase (JAK) ... Read More
-
PD-1 and PD-L1 Inhibitors- Competitive Landscape, 2022
... therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage PD-1 AND PD-L1 Inhibitors: Understanding PD-1 AND PD-L1 ... Read More
-
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape. Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of ... Read More
-
Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... are developed by companies and remaining by the universities/institutes. The latest report Glycoprotein 41 - Drugs In Development, 2022, outlays comprehensive information on the Glycoprotein 41 (gp41) targeted therapeutics, complete with analysis by indications, stage ... Read More
-
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... the ubiquitin pathway of protein degradation. It is commonly associated with regulatory complexes, which include the 19S Proteasome, the PA28 alpha/beta complex, or the PA28 gamma complex. The 20S Proteasome is composed of 28 subunits ... Read More
-
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... published report 'C-C Chemokine Receptor Type 5 - Drugs In Development, 2022'; C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 16 molecules. Out ... Read More
-
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, ... Read More
-
Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... In Development, 2022'; Glucagon Like Peptide 2 Receptor (GLP2R) pipeline Target constitutes close to 18 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. Glucagon Like Peptide 2 ... Read More
-
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Glycogen synthase kinase 3 beta also known as GSK3B is an enzyme encoded by the GSK3B. It constitutively activate ... Read More
-
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase C Epsilon Type - Drugs In Development, 2022'; Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 11 molecules are ... Read More
-
Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022'; Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 23 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. Catenin Beta 1 (Beta ... Read More
-
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... or EC 2.7.1.2) pipeline Target constitutes close to 21 molecules. Out of which approximately 19 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase - Drugs In Development, 2022, outlays ... Read More
-
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) pipeline Target constitutes close to 45 molecules. Out of which approximately 41 molecules are developed by companies and remaining by the universities/institutes. The latest ... Read More
-
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 - Drugs In Development, 2022, outlays comprehensive information ... Read More
Research Assistance
